lung-cancer

Documents about lung-cancer

• Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer#208427ClinicalTrials.gov
• Ethical and legal concerns in artificial intelligence applications for the diagnosis and treatment of lung cancer: a scoping review#19915DOAJ
• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)#136346ClinicalTrials.gov
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases#154655ClinicalTrials.gov
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer#287563ClinicalTrials.gov
• Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids#303746ClinicalTrials.gov
• An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer#411329ClinicalTrials.gov
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries#6802OpenAlex
• Integrated machine learning risk model for predicting radiation pneumonitis in lung cancer patients with interstitial lung disease.#9709PubMed
• Analysis of Circulating Tumor Markers in Blood - ALCINA 5#238089ClinicalTrials.gov
• Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer#363615ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer#398184ClinicalTrials.gov
• Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease#141005ClinicalTrials.gov
• ITIL-306 in Advanced Solid Tumors#226274ClinicalTrials.gov
• Improving access and uptake of lung cancer screening with a focus on health inequity: the views of professionals involved in the UK NHS lung cancer screening programme.#25560NCBI PubMed Central
• Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration#288214HAL (France)
• FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer#312103HAL (France)
• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy#442079ClinicalTrials.gov
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors#383570ClinicalTrials.gov
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older#208283ClinicalTrials.gov
• A lung microbial signature for postoperative recurrence in stage I-II non-small cell lung cancer.#9077NCBI PubMed Central
• Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma#314344ClinicalTrials.gov
• Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status#398323ClinicalTrials.gov
• Diet‐wide association study of 92 foods and nutrients and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study#218018HAL (France)
• Evolutionary characterization of lung cancer metastasis.#218995NCBI PubMed Central
• Phenotypic and histological distribution analysis identify mast cell heterogeneity in non-small cell lung cancer#161285HAL (France)
• An Atypical Surgical Case of Lung Cancer With Unilateral Absence of the Pulmonary Artery, With Only the Superior Branch Remaining#194794OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy#208432ClinicalTrials.gov
• Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer#246713HAL (France)
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated#303739ClinicalTrials.gov
• Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases#346941ClinicalTrials.gov
• Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers#388220HAL (France)
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries#6826OpenAlex
• A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies#127579ClinicalTrials.gov
• A Clinical Evaluation of the Aliya™ System in Late Stage Cancer#125826ClinicalTrials.gov
• Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC#162483ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#349973ClinicalTrials.gov
• Standardization of a Platform of Preclinical Models Derived From NSCLC Patients#407729ClinicalTrials.gov
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas#353265ClinicalTrials.gov
• Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.#405169ClinicalTrials.gov
• Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma#125847ClinicalTrials.gov
• Association of Psychological Distress in Patients With Lung Cancer#363624ClinicalTrials.gov
• A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer#435744ClinicalTrials.gov
• Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.#253008ClinicalTrials.gov
• DeepGR: a deep-learning prognostic model based on glycolytic radiomics for non-small cell lung cancer#28883HAL (France)
• Late and isolated pseudoprogressions of non-small cell lung cancer under anti-PD-1 in the adrenal glands: about two cases#257552HAL (France)
• Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer#330406IRIS
• Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer#343825ClinicalTrials.gov
• A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens#426789ClinicalTrials.gov